Minimal Anticipated Biological Effect Level [MABEL]

« Back to Glossary Index

Print this page

The Minimal Anticipated Biological Effect Level (MABEL) is the anticipated dose needed to result in a biological effect in participants of a clinical trial. It is a safety window based on pharmacological threshold. The minimal anticipated biological effect level is recommended as a useful approach to calculate the Safe Starting Dose, as it is the lowest dose that is active.

Related Articles:

Setting the ‘first-in-human’ dose
Careful consideration of various factors is necessary before progressing from non-clinical to clinical studies and setting the first-in-human dose.

« Back to Glossary Index

Related Terms:

Find Out More

Toolbox

Guidance

Glossary

Creative Commons

Webinars